1. Home
  2. ETNB
  3. ETNB News

Latest 89bio Inc. (ETNB) News on May 25, 2024

89bio to Present 48-Week Data from ENLIVEN Phase 2b Pegozafermin Trial in Metabolic Dysfunction-Associated Steatohepatitis (MASH) at EASL International Liver Congress

GlobeNewswire

3 days ago

89bio to Present 48-Week Data from ENLIVEN Phase 2b Pegozafermin Trial in Metabolic Dysfunction-Associated Steatohepatitis (MASH) at EASL International Liver Congress

Associated Press Finance

4 months ago

MaxLinear: Q4 Earnings Snapshot

Associated Press Finance

4 months ago

First Financial: Q4 Earnings Snapshot

Associated Press Finance

4 months ago

Banner: Q4 Earnings Snapshot

Share on Social Networks: